| Mr Sean Mcgowan, CRNA | |
|
2401 W Belvedere Ave, Baltimore, MD 21215-5216 | |
| (410) 601-5209 | |
| (410) 601-8841 |
| Full Name | Mr Sean Mcgowan |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 2401 W Belvedere Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376847384 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R149833 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthetic Solutions Inc | 4587901129 | 8 |
| Carolina Anesthesia Associates Pa | 1456251057 | 66 |
| Carolina Regional Anesthesia Pllc | 5496921769 | 49 |
News Archive
DiFUSION Technologies Inc., a medical device company focused on the development and commercialization of its proprietary CleanFUZE anti-microbial technology for orthopedic implants, announced today the 510(k) clearance of its new Xiphos line of posterior interbody devices indicated for intervertebral body fusion of the lumbar spine, from L2 to SI, in skeletally mature patients who have had six months of non-operative treatment.
Disease outbreaks are scary, especially when it's a new virus that's infecting people on a large scale.
Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
Dopamine is a neurotransmitter involved in everything from higher cognitive functions to motor control, motivation, arousal, reinforcement, and sexual gratification, the receptors it acts on have been a longstanding target for treating disorders like Parkinson's disease, which is caused by the degeneration of dopamine-using neurons that control movement.
› Verified 1 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
DiFUSION Technologies Inc., a medical device company focused on the development and commercialization of its proprietary CleanFUZE anti-microbial technology for orthopedic implants, announced today the 510(k) clearance of its new Xiphos line of posterior interbody devices indicated for intervertebral body fusion of the lumbar spine, from L2 to SI, in skeletally mature patients who have had six months of non-operative treatment.
Disease outbreaks are scary, especially when it's a new virus that's infecting people on a large scale.
Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
Dopamine is a neurotransmitter involved in everything from higher cognitive functions to motor control, motivation, arousal, reinforcement, and sexual gratification, the receptors it acts on have been a longstanding target for treating disorders like Parkinson's disease, which is caused by the degeneration of dopamine-using neurons that control movement.
› Verified 1 days ago
| Entity Name | Metropolitan Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720387954 PECOS PAC ID: 2860662996 Enrollment ID: O20110829000644 |
News Archive
DiFUSION Technologies Inc., a medical device company focused on the development and commercialization of its proprietary CleanFUZE anti-microbial technology for orthopedic implants, announced today the 510(k) clearance of its new Xiphos line of posterior interbody devices indicated for intervertebral body fusion of the lumbar spine, from L2 to SI, in skeletally mature patients who have had six months of non-operative treatment.
Disease outbreaks are scary, especially when it's a new virus that's infecting people on a large scale.
Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
Dopamine is a neurotransmitter involved in everything from higher cognitive functions to motor control, motivation, arousal, reinforcement, and sexual gratification, the receptors it acts on have been a longstanding target for treating disorders like Parkinson's disease, which is caused by the degeneration of dopamine-using neurons that control movement.
› Verified 1 days ago
| Entity Name | Complete Anesthesia Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932464492 PECOS PAC ID: 7214187210 Enrollment ID: O20121029000661 |
News Archive
DiFUSION Technologies Inc., a medical device company focused on the development and commercialization of its proprietary CleanFUZE anti-microbial technology for orthopedic implants, announced today the 510(k) clearance of its new Xiphos line of posterior interbody devices indicated for intervertebral body fusion of the lumbar spine, from L2 to SI, in skeletally mature patients who have had six months of non-operative treatment.
Disease outbreaks are scary, especially when it's a new virus that's infecting people on a large scale.
Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
Dopamine is a neurotransmitter involved in everything from higher cognitive functions to motor control, motivation, arousal, reinforcement, and sexual gratification, the receptors it acts on have been a longstanding target for treating disorders like Parkinson's disease, which is caused by the degeneration of dopamine-using neurons that control movement.
› Verified 1 days ago
| Entity Name | Anesthetic Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477022259 PECOS PAC ID: 4587901129 Enrollment ID: O20190121001182 |
News Archive
DiFUSION Technologies Inc., a medical device company focused on the development and commercialization of its proprietary CleanFUZE anti-microbial technology for orthopedic implants, announced today the 510(k) clearance of its new Xiphos line of posterior interbody devices indicated for intervertebral body fusion of the lumbar spine, from L2 to SI, in skeletally mature patients who have had six months of non-operative treatment.
Disease outbreaks are scary, especially when it's a new virus that's infecting people on a large scale.
Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
Dopamine is a neurotransmitter involved in everything from higher cognitive functions to motor control, motivation, arousal, reinforcement, and sexual gratification, the receptors it acts on have been a longstanding target for treating disorders like Parkinson's disease, which is caused by the degeneration of dopamine-using neurons that control movement.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Sean Mcgowan, CRNA 68 S Service Rd, Suite 350, Melville, NY 11747-2354 Ph: (516) 945-3000 | Mr Sean Mcgowan, CRNA 2401 W Belvedere Ave, Baltimore, MD 21215-5216 Ph: (410) 601-5209 |
News Archive
DiFUSION Technologies Inc., a medical device company focused on the development and commercialization of its proprietary CleanFUZE anti-microbial technology for orthopedic implants, announced today the 510(k) clearance of its new Xiphos line of posterior interbody devices indicated for intervertebral body fusion of the lumbar spine, from L2 to SI, in skeletally mature patients who have had six months of non-operative treatment.
Disease outbreaks are scary, especially when it's a new virus that's infecting people on a large scale.
Celsion Corporation, a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer".
Dopamine is a neurotransmitter involved in everything from higher cognitive functions to motor control, motivation, arousal, reinforcement, and sexual gratification, the receptors it acts on have been a longstanding target for treating disorders like Parkinson's disease, which is caused by the degeneration of dopamine-using neurons that control movement.
› Verified 1 days ago
Ms. Jennifer Renee Pease Moreno, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: Jhu 600 N Wolfe St, Dept Anesthesia Critical Care Medicine- Blalock 14th Fl, Baltimore, MD 21287 Phone: 410-955-4552 | |
Kristen Marll, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-601-5209 | |
Mrs. Victoria Volta Manger, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 S Caton Ave, Baltimore, MD 21229 Phone: 667-234-3045 | |
Duncan Mcelfresh, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2401 W Belvedere Ave, Anesthesia Department, Baltimore, MD 21215 Phone: 410-601-5209 Fax: 410-601-9744 | |
Mr. Michael W Hoban, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 301 Saint Paul St, Baltimore, MD 21202 Phone: 410-332-9375 | |
Mrs. Dama Reter Yekeson-koffa, RN, SRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4940 Eastern Ave, Anesthesia Department Bayview Medical Center, Baltimore, MD 21224 Phone: 443-694-8960 Fax: 410-356-5821 | |
Kelly Mccarthy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-8667 |